Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a global public health emergency, and new therapeutics are needed. This article reports the potential drug target and mechanism of action of Arbidol (umifenovir) to treat coronavirus disease 2019 (COVID-19). Molecular dynam...

Descripción completa

Detalles Bibliográficos
Autor principal: Vankadari, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187825/
https://www.ncbi.nlm.nih.gov/pubmed/32360231
http://dx.doi.org/10.1016/j.ijantimicag.2020.105998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187825/
https://www.ncbi.nlm.nih.gov/pubmed/32360231
http://dx.doi.org/10.1016/j.ijantimicag.2020.105998

Ejemplares similares